Conventional pancreatic cancer treatments face a critical hurdle due to the dense tumor microenvironment (TME). This biological barrier surrounds the tumor, severely limiting the infiltration of chemotherapy agents and immune cells. While…
Continue Reading
News Source: medicalxpress.com
Leave a Reply